OCM
LLY icon

Orser Capital Management’s Eli Lilly LLY Stock Holding History

Orser Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,134
Closed -$1.76M – 52
2025
Q1 		$1.76M Hold
2,134
– – 1.29% 24
2024
Q4 		$1.65M Sell
2,134
-10
-0.5% -$8.28K 1.13% 25
2024
Q3 		$1.9M Sell
2,144
-10
-0.5% -$8.99K 1.36% 22
2024
Q2 		$1.95M Buy
2,154
+7
+0.3% +$5.6K 1.47% 21
2024
Q1 		$1.67M Buy
2,147
+36
+2% +$25.6K 1.57% 23
2023
Q4 		$1.23M Sell
2,111
-209
-9% -$122K 1.34% 26
2023
Q3 		$1.25M Buy
+2,320
New +$1.2M 1.23% 29

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Orser Capital Management's LLY Position: Q2 2025 in Review

Orser Capital Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 2,134 shares — an estimated $1.76M sold.

Orser Capital Management first reported a position in LLY in Q3 2023 and held it in 7 quarters. The position peaked at $1.95M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Orser Capital Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Orser Capital Management sold 2,134 Eli Lilly shares in Q2 2025, an estimated $1.76M.
  • Orser Capital Management first reported a position in Eli Lilly in Q3 2023 and held it in 7 quarters.
  • Orser Capital Management's Eli Lilly position peaked at $1.95M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Orser Capital Management's 13F filing for Q2 2025, filed 9 Jul 2025.